The importance of this cancer research cannot be overstated. Phase I and II clinical trials are underfunded, yet have the greatest patient impact in conquering cancer
Medinah, Ill. (PRWEB) May 07, 2015
Gateway for Cancer Research raised an amazing $218,359 at the Medinah Country Club on Monday, May 4, 2015, to fund ground-breaking phase I and phase II cancer clinical trials. The funds raised will advance Gateway’s mission to fund meaningful and breakthrough clinical trials worldwide that help people living with cancer to feel better, live longer and conquer cancer TODAY!.
The annual Cures Ahead Golf Invitational is put on by Gateway for Cancer Research in partnership with Cancer Treatment Centers of America® as well as the IT innovation company AHEAD®. The collaboration between Gateway, CTCA and AHEAD produced a sold-out event with 100 golfers representing more than 30 companies turning out in support of Gateway’s mission.
“The importance of this cancer research cannot be overstated. Phase I and II clinical trials are underfunded, yet have the greatest patient impact in conquering cancer.” – Teresa Hall Bartels, President, Gateway for Cancer Research.
CuresAhead Golf Invitational premier mission partners include Cancer Treatment Centers of America® and Ahead®, EMC, International Capital & Management Company (ICMC), AT&T, Bob & Cindy Mayo, Brown Legacy Group, Call One, CenturyLink, Cisco, Insight, Inverness Wealth, Kailo, The Bonner Family, The PrivateBank, Wholesale Floors, Katten Muchin Rosenman, LLP, Burwood Group, Sirius Computer Solutions, Level 3, OneNeck IT Solutions, Kronos & Workday.
For more on Gateway for Cancer Research and the innovative, patient-centered cancer research studies it funds, visit http://www.GatewayCR.org.
# # #
About Gateway for Cancer Research℠
Gateway for Cancer Research is a nonprofit 501(c)(3) organization committed to funding innovative cancer research studies that help today’s cancer patients feel better, live longer and conquer cancer TODAY!. Thanks to generous underwriting by Cancer Treatment Centers of America®, 99 cents of every dollar Gateway receives directly funds phase I and phase II cancer clinical trials at leading research institutions across the country and abroad. Since 1991 Gateway has supported more than 120 clinical trials and funded millions in leading-edge research, including blending the best of conventional, and complementary and alternative therapies. Get involved today by visiting GatewayCR.org, like us on Facebook at facebook.com/demandcures and join the conversation on Twitter @DemandCures. #BeAGateway.